Cargando…

Multicentre survey of retinopathy of prematurity in Indonesia

BACKGROUND: The incidence of retinopathy of prematurity (ROP) is higher in Indonesia than in high-income countries. In order to reduce the incidence of the disease, a protocol on preventing, screening and treating ROP was published in Indonesia in 2010. To assist the practical implementation of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Siswanto, J Edy, Bos, Arend F, Dijk, Peter H, Rohsiswatmo, Rinawati, Irawan, Gatot, Sulistijono, Eko, Sianturi, Pertin, Wisnumurti, Dewi A, Wilar, Rocky, Sauer, Pieter J J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831712/
https://www.ncbi.nlm.nih.gov/pubmed/33532628
http://dx.doi.org/10.1136/bmjpo-2020-000761
_version_ 1783641675226152960
author Siswanto, J Edy
Bos, Arend F
Dijk, Peter H
Rohsiswatmo, Rinawati
Irawan, Gatot
Sulistijono, Eko
Sianturi, Pertin
Wisnumurti, Dewi A
Wilar, Rocky
Sauer, Pieter J J
author_facet Siswanto, J Edy
Bos, Arend F
Dijk, Peter H
Rohsiswatmo, Rinawati
Irawan, Gatot
Sulistijono, Eko
Sianturi, Pertin
Wisnumurti, Dewi A
Wilar, Rocky
Sauer, Pieter J J
author_sort Siswanto, J Edy
collection PubMed
description BACKGROUND: The incidence of retinopathy of prematurity (ROP) is higher in Indonesia than in high-income countries. In order to reduce the incidence of the disease, a protocol on preventing, screening and treating ROP was published in Indonesia in 2010. To assist the practical implementation of the protocol, meetings were held in all Indonesia regions, calling attention to the high incidence of ROP and the methods to reduce it. In addition, national health insurance was introduced in 2014, making ROP screening and treatment accessible to more infants. OBJECTIVE: To evaluate whether the introduction of both the guideline drawing attention to the high incidence of ROP and national health insurance may have influenced the incidence of the disease in Indonesia. SETTING: Data were collected from 34 hospitals with different levels of care: national referral centres, university-based hospitals, and public and private hospitals. METHODS: A survey was administered with questions on admission numbers, mortality rates, ROP incidence, and its stages for 2016–2017 in relation to gestational age and birth weight. RESULTS: We identified 12 115 eligible infants with a gestational age of less than 34 weeks. Mortality was 24% and any stage ROP 6.7%. The mortality in infants aged less than 28 weeks was 67%, the incidence of all-stage ROP 18% and severe ROP 4%. In the group aged 28–32 weeks, the mortality was 24%, all-stage ROP 7% and severe ROP 4%–5%. Both mortality and the incidence of ROP were highest in university-based hospitals. CONCLUSIONS: In the 2016–2017 period, the infant mortality rate before 32 weeks of age was higher in Indonesia than in high-income countries, but the incidence of ROP was comparable. This incidence is likely an underestimation due to the high mortality rate. The ROP incidence in 2016–2017 is lower than in surveys conducted before 2015. This decline is likely due to a higher practitioner awareness about ROP and national health insurance implementation in Indonesia.
format Online
Article
Text
id pubmed-7831712
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78317122021-02-01 Multicentre survey of retinopathy of prematurity in Indonesia Siswanto, J Edy Bos, Arend F Dijk, Peter H Rohsiswatmo, Rinawati Irawan, Gatot Sulistijono, Eko Sianturi, Pertin Wisnumurti, Dewi A Wilar, Rocky Sauer, Pieter J J BMJ Paediatr Open Ophthalmology BACKGROUND: The incidence of retinopathy of prematurity (ROP) is higher in Indonesia than in high-income countries. In order to reduce the incidence of the disease, a protocol on preventing, screening and treating ROP was published in Indonesia in 2010. To assist the practical implementation of the protocol, meetings were held in all Indonesia regions, calling attention to the high incidence of ROP and the methods to reduce it. In addition, national health insurance was introduced in 2014, making ROP screening and treatment accessible to more infants. OBJECTIVE: To evaluate whether the introduction of both the guideline drawing attention to the high incidence of ROP and national health insurance may have influenced the incidence of the disease in Indonesia. SETTING: Data were collected from 34 hospitals with different levels of care: national referral centres, university-based hospitals, and public and private hospitals. METHODS: A survey was administered with questions on admission numbers, mortality rates, ROP incidence, and its stages for 2016–2017 in relation to gestational age and birth weight. RESULTS: We identified 12 115 eligible infants with a gestational age of less than 34 weeks. Mortality was 24% and any stage ROP 6.7%. The mortality in infants aged less than 28 weeks was 67%, the incidence of all-stage ROP 18% and severe ROP 4%. In the group aged 28–32 weeks, the mortality was 24%, all-stage ROP 7% and severe ROP 4%–5%. Both mortality and the incidence of ROP were highest in university-based hospitals. CONCLUSIONS: In the 2016–2017 period, the infant mortality rate before 32 weeks of age was higher in Indonesia than in high-income countries, but the incidence of ROP was comparable. This incidence is likely an underestimation due to the high mortality rate. The ROP incidence in 2016–2017 is lower than in surveys conducted before 2015. This decline is likely due to a higher practitioner awareness about ROP and national health insurance implementation in Indonesia. BMJ Publishing Group 2021-01-22 /pmc/articles/PMC7831712/ /pubmed/33532628 http://dx.doi.org/10.1136/bmjpo-2020-000761 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Ophthalmology
Siswanto, J Edy
Bos, Arend F
Dijk, Peter H
Rohsiswatmo, Rinawati
Irawan, Gatot
Sulistijono, Eko
Sianturi, Pertin
Wisnumurti, Dewi A
Wilar, Rocky
Sauer, Pieter J J
Multicentre survey of retinopathy of prematurity in Indonesia
title Multicentre survey of retinopathy of prematurity in Indonesia
title_full Multicentre survey of retinopathy of prematurity in Indonesia
title_fullStr Multicentre survey of retinopathy of prematurity in Indonesia
title_full_unstemmed Multicentre survey of retinopathy of prematurity in Indonesia
title_short Multicentre survey of retinopathy of prematurity in Indonesia
title_sort multicentre survey of retinopathy of prematurity in indonesia
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831712/
https://www.ncbi.nlm.nih.gov/pubmed/33532628
http://dx.doi.org/10.1136/bmjpo-2020-000761
work_keys_str_mv AT siswantojedy multicentresurveyofretinopathyofprematurityinindonesia
AT bosarendf multicentresurveyofretinopathyofprematurityinindonesia
AT dijkpeterh multicentresurveyofretinopathyofprematurityinindonesia
AT rohsiswatmorinawati multicentresurveyofretinopathyofprematurityinindonesia
AT irawangatot multicentresurveyofretinopathyofprematurityinindonesia
AT sulistijonoeko multicentresurveyofretinopathyofprematurityinindonesia
AT sianturipertin multicentresurveyofretinopathyofprematurityinindonesia
AT wisnumurtidewia multicentresurveyofretinopathyofprematurityinindonesia
AT wilarrocky multicentresurveyofretinopathyofprematurityinindonesia
AT sauerpieterjj multicentresurveyofretinopathyofprematurityinindonesia
AT multicentresurveyofretinopathyofprematurityinindonesia